Abstract
French researchers have shown that their dendrimer against the receptor for M-CSF blocks inflammation, cartilage degradation and bone erosion in mouse models of rheumatoid arthritis. The team is getting the compound ready for clinical trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have